Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamaya

Showing results (341-350 of 481) with videos related to

Pageof 49
Sort By:
Plos One|April 27, 2021
Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn diseaseNatsuki Ishida, Tomohiro Higuchi, Takahiro Miyazu, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|August 13, 2025
Lymphocyte Fractions as Indicators of T-Helper 1/T-Helper 2 Cytokine Profiles in Inflammatory Bowel DiseaseYusuke Asai, Natsuki Ishida, Tomohiro Takebe, et al.
IJU Case Reports|July 3, 2025
A Case of Delayed Refractory <i>Mycobacterium mageritense</i> Abdominal Wall Abscess in a Kidney Transplant RecipientHisashi Sakurai, Teppei Okamoto, Tomoko Hamaya, et al.
Journal of Neuromuscular Diseases|May 21, 2025
Short- and long-term natural history of three neurodegenerative biomarkers among middle-aged and older adultsRikuta Hamaya, Pamela M Rist, Varant Kupelian, et al.
Inflammatory Bowel Diseases|May 21, 2025
Usefulness of Prostaglandin E-Major Urinary Metabolite in Monitoring Crohn's Disease Activity: A Prospective Cross-Sectional StudyNatsuki Ishida, Satoshi Tamura, Tomohiro Takebe, et al.
Oncotarget|March 17, 2018
<i>MBD4</i> frameshift mutation caused by DNA mismatch repair deficiency enhances cytotoxicity by trifluridine, an active antitumor agent of TAS-102, in colorectal cancer cellsSatoshi Suzuki, Moriya Iwaizumi, Hidetaka Yamada, et al.
BMC Gastroenterology|April 21, 2020
Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitisNatsuki Ishida, Takahiro Miyazu, Ryosuke Takano, et al.
World Journal of Emergency Medicine|March 24, 2016
Invasive group B streptococcal infection in a patient with post splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertensionTomoya Okazaki, Toru Hifumi, Arisa Manabe, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2019
Prognostic value of post-intervention fractional flow reserve after intravascular ultrasound-guided second-generation drug-eluting coronary stentingMasahiro Hoshino, Yoshihisa Kanaji, Rikuta Hamaya, et al.
Gastroenterology Research and Practice|May 5, 2025
Fecal Calprotectin as a Biomarker of Crohn's Disease in Patients With Short Disease Durations: A Prospective, Single-Center, Cross-Sectional StudyNatsuki Ishida, Shunya Onoue, Tomohiro Takebe, et al.
Pageof 49

Showing results (341-350 of 481) with videos related to

Sort By:
Pageof 49
Plos One|April 27, 2021
Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn diseaseNatsuki Ishida, Tomohiro Higuchi, Takahiro Miyazu, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|August 13, 2025
Lymphocyte Fractions as Indicators of T-Helper 1/T-Helper 2 Cytokine Profiles in Inflammatory Bowel DiseaseYusuke Asai, Natsuki Ishida, Tomohiro Takebe, et al.
IJU Case Reports|July 3, 2025
A Case of Delayed Refractory <i>Mycobacterium mageritense</i> Abdominal Wall Abscess in a Kidney Transplant RecipientHisashi Sakurai, Teppei Okamoto, Tomoko Hamaya, et al.
Journal of Neuromuscular Diseases|May 21, 2025
Short- and long-term natural history of three neurodegenerative biomarkers among middle-aged and older adultsRikuta Hamaya, Pamela M Rist, Varant Kupelian, et al.
Inflammatory Bowel Diseases|May 21, 2025
Usefulness of Prostaglandin E-Major Urinary Metabolite in Monitoring Crohn's Disease Activity: A Prospective Cross-Sectional StudyNatsuki Ishida, Satoshi Tamura, Tomohiro Takebe, et al.
Oncotarget|March 17, 2018
<i>MBD4</i> frameshift mutation caused by DNA mismatch repair deficiency enhances cytotoxicity by trifluridine, an active antitumor agent of TAS-102, in colorectal cancer cellsSatoshi Suzuki, Moriya Iwaizumi, Hidetaka Yamada, et al.
BMC Gastroenterology|April 21, 2020
Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitisNatsuki Ishida, Takahiro Miyazu, Ryosuke Takano, et al.
World Journal of Emergency Medicine|March 24, 2016
Invasive group B streptococcal infection in a patient with post splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertensionTomoya Okazaki, Toru Hifumi, Arisa Manabe, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2019
Prognostic value of post-intervention fractional flow reserve after intravascular ultrasound-guided second-generation drug-eluting coronary stentingMasahiro Hoshino, Yoshihisa Kanaji, Rikuta Hamaya, et al.
Gastroenterology Research and Practice|May 5, 2025
Fecal Calprotectin as a Biomarker of Crohn's Disease in Patients With Short Disease Durations: A Prospective, Single-Center, Cross-Sectional StudyNatsuki Ishida, Shunya Onoue, Tomohiro Takebe, et al.
Pageof 49